Please use this identifier to cite or link to this item:
|Title:||Factors influencing age at diagnosis of primary ciliary dyskinesia in European children||Authors:||Kuehni, Claudia Elisabeth
Frischer, Thomas H.
Strippoli, Marie Pierre Francoise
Bush, Andrew J.
Nielsen, Kim Gjerum Jerum
Escribano, Amparo Fernandez
Lucase, J. S A
Yiallouros, Panayiotis K.
O'Callaghan, Christopher Liam
|Major Field of Science:||Medical and Health Sciences||Field Category:||Clinical Medicine||Keywords:||Bronchiectasis;Ciliary motility disorders;Diagnosis;Epidemiology;Kartagener syndrome;Primary ciliary dyskinesia||Issue Date:||1-Dec-2010||Source:||European Respiratory Journal, 2010, vol. 36, no. 6, pp. 1248-1258||Volume:||36||Issue:||6||Start page:||1248||End page:||1258||Journal:||European Respiratory Journal||Abstract:||Primary ciliary dyskinesia (PCD) is a hereditary disorder of mucociliary clearance causing chronic upper and lower airways disease. We determined the number of patients with diagnosed PCD across Europe, described age at diagnosis and determined risk factors for late diagnosis. Centres treating children with PCD in Europe answered questionnaires and provided anonymous patient lists. In total, 223 centres from 26 countries reported 1,009 patients aged <20 yrs. Reported cases per million children (for 5-14 yr olds) were highest in Cyprus (111), Switzerland (47) and Denmark (46). Overall, 57% were males and 48% had situs inversus. Median age at diagnosis was 5.3 yrs, lower in children with situs inversus (3.5 versus 5.8 yrs; p<0.001) and in children treated in large centres (4.1 versus 4.8 yrs; p=0.002). Adjusted age at diagnosis was 5.0 yrs in Western Europe, 4.8 yrs in the British Isles, 5.5 yrs in Northern Europe, 6.8 yrs in Eastern Europe and 6.5 yrs in Southern Europe (p<0.001). This strongly correlated with general government expenditures on health (p<0.001). This European survey suggests that PCD in children is under-diagnosed and diagnosed late, particularly in countries with low health expenditures. Prospective studies should assess the impact this delay might have on patient prognosis and on health economic costs across Europe.||ISSN:||1399-3003||DOI:||10.1183/09031936.00001010||Rights:||© ERS||Type:||Article||Affiliation :||University of Bern
Universitätsklinik für Kinder- und Jugendheilkunde
Royal Brompton Hospital
Danish Paediatric Pulmonary Service
University of Valencia
University of Southampton
Cyprus University of Technology
Medical University of Graz
University of Leicester
University of Padova
|Appears in Collections:||Άρθρα/Articles|
checked on Aug 2, 2021
WEB OF SCIENCETM
checked on Apr 22, 2021
checked on Aug 2, 2021
Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.